CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisKommentar/debat/letter to the editorForskningpeer review

OriginalsprogEngelsk
TidsskriftLeukemia and Lymphoma
Vol/bind63
Nummer6
Sider (fra-til)1479-1483
Antal sider5
ISSN1042-8194
DOI
StatusUdgivet - maj 2022

Bibliografisk note

Funding Information:
This work was made possible through Aarhus University, the Karen Elise Jensen Foundation, the Eva and Henry Fraenkel Foundation, the Einar Willumsen’s Memorial Foundation, and the Danish Lymphoma Group.

Se relationer på Aarhus Universitet Citationsformater

ID: 278011186